As one of the major cytokines regulating inflammatory response in COVID-19, serum interleukin-6 (IL-6) has been observed to correlate with mortality, and proposed as a biomarker predictive of disease severity (Liu et al., 2020; McElvaney et al., 2021). Here, IL6 is linked to COVID-19.